The Role of Artificial Intelligence in Accurate Interpretation of HER2 Immunohistochemical Scores 0 and 1+ in Breast Cancer
Author:
Publisher
Elsevier BV
Subject
Pathology and Forensic Medicine
Reference29 articles.
1. Comprehensive molecular portraits of human breast tumours;Koboldt;Nature,2012
2. Trastuzumab deruxtecan in previously treated Her2-low advanced breast cancer;Modi;N Engl J Med,2022
3. Clinical and molecular characteristics of Her2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials;Denkert;Lancet Oncol,2021
4. Clinical, pathological, and Pam50 gene expression features of Her2-low breast cancer;Schettini;NPJ Breast Cancer,2021
5. Distinguishing score 0 from score 1+ in Her2 immunohistochemistry-negative breast cancer: clinical and pathobiological relevance;Lambein;Am J Clin Pathol,2013
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Computational pathology in the identification of HER2-low breast cancer: Opportunities and challenges;Journal of Pathology Informatics;2024-12
2. Understanding the spectrum of HER2 status in breast cancer: From HER2-positive to ultra-low HER2;Pathology - Research and Practice;2024-10
3. Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides;Breast Cancer Research;2024-08-19
4. The Performance and Clinical Applicability of HER2 Digital Image Analysis in Breast Cancer: A Systematic Review;Cancers;2024-08-03
5. Artificial intelligence for assisted HER2 immunohistochemistry evaluation of breast cancer: A systematic review and meta-analysis;Pathology - Research and Practice;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3